Overview

Drug Based Side Effects Treatment Market Introduction

Although the approved drugs are expected to be effective and beneficial in treating health issues beyond their known risks, they can potentially result in unexpected reactions. This can result from a prescribed or OTC drugs and are known as Drug based side-effects. Drug based side-effects can range from minor problems like flu-symptoms to life-threatening issues for example complications during pregnancy like birth defects and heart attacks. Hence it is of utmost importance that such side-effects are intervened in a timely fashion with competent treatment. The treatments include switching to more agreeable medication or using a combination of a drug product under the guidance of healthcare experts. Side effects can also be treated with lifestyle changes, dietary changes, and adjusting the dosages with the consultation from the healthcare provider.

The increase in addictive behaviours requiring drug rehabilitation, the discovery of novel drugs, significant cancer patient’s population undergoing chemotherapy, on-the-counter availability of medicinal and recreational cannabis products are some of the recently developed stimulants to the drug based side effects treatment market. Significant population with hypersensitivity to anti-depressants, stimulants, anti-emetics and allergic reactions to nutritional supplements also add up to the mentions stimulants. Apart from the above factors the stringent government regulations and varying drug safety norms by the Food and Drug Association(FDA) are causing upward drift in the drug based side effects treatment market.

Innovation Areas to Focus on For Competitive Advantage Include:
•    Effective treatment for side effects caused by drugs whose side effects go undetected with the right dosage
•    Counter treatments for drug interactions when unintentionally mixed with certain elements for example cholesterol medicines along with grapefruit juice can affect blood levels
•    Side effects treatment for drugs causing birth defect and are infant-friendly
•    Dealing with arthritis and cancer treatment side effects that cause loss of vital blood components like RBC, WBC or causing blood clots

At present North America dominates the Drug-Based side effects treatment market due to the well-established healthcare sector, R&D investments and adoption of advanced technologies. Europe is estimated to be the second largest region in terms of market penetration. Rising awareness about drug side-effects and increase in healthcare investments in the Asia Pacific has sprouted lucrative growth prospects for the market during the forecast period. This is followed by Latin America while the rest of the world is to demonstrate growth at a gentle pace. 

Key Market Players include
Pfizer Inc., Johnson & Johnson, Novartis AG, Teva Pharmaceuticals, Sanofi S.A., 

Drug-Based Side Effects Treatment Market Segmentation:

By Drug Type
•    Antidepressant
•    Stimulants
•    NSAIDS
•    Anti-emetics
•    Nutrition Supplements
•    Others    

By Distribution Channel
•    Hospital Pharmacies
•    Retail Pharmacies
•    E-Commerce Channels

By Region
•    North America
•    Latin America
•    Europe
•    Asia Pacific
•    Middle East and Africa

Competitive Landscape:  
•    Tier 1 players- established companies in the market with a major market share
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants  

FutureWise Key Takeaways 
•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

Objectives of the Study: 
•    To provide with an exhaustive analysis on the global drug based side effects treatment market on the basis of application type, distribution channel, and region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and Middle East and Africa
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies  

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
    2.1. Research Data 
         2.1.1. Secondary Data
                2.1.1.1. Key Data from Secondary Sources
         2.1.2. Primary Data
                2.1.2.1. Key Data from Primary Sources
    2.2. Market Size Estimation 
    2.3. Market Breakdown and Data Triangulation 
    2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Drug Based Side Effects Treatment Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Type Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Drug Based Side Effects Treatment Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Drug Based Side Effects Treatment Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Type Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Type Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Drug Based Side Effects Treatment Market, By Drug type Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Antidepressant
   7.2. Stimulants
   7.3. NSAIDS
   7.4. Anti-emetics
   7.5. Nutrition Supplements
   7.6. Others    

8. Drug Based Side Effects Treatment Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Hospital Pharmacies 
   8.2. Retail Pharmacies
   8.3. E-Commerce Channels

9. North America Drug Based Side Effects Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   9.1. Introduction
   9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
        9.2.1. U.S.A
        9.2.2. Canada
        9.2.3. Mexico
   9.3. Market Size (USD Million) Forecast for North America 2022-2028

10. Latin America Drug Based Side Effects Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. Brazil
          10.2.2. Venezuela
          10.2.3. Argentina
          10.2.4. Rest of Latin America
    10.3. Market Size (USD Million) Forecast for Latin America 2022-2028

11. Europe Drug Based Side Effects Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Germany
          11.2.2. U.K         
          11.2.3. France
          11.2.4. Italy
          11.2.5. Spain
          11.2.6. Russia
          11.2.7. Poland
          11.2.8. Rest of Europe
    11.3. Market Size (USD Million) Forecast for Europe 2022-2028

12. Asia Pacific Drug Based Side Effects Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Japan
          12.2.2. China
          12.2.3. India
          12.2.4. Australia and New Zealand
          12.2.5. ASEAN
          12.2.6. Rest of Asia Pacific
    12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. GCC
          13.2.2. Israel
          13.2.3. South Africa
          13.2.4. Rest of MEA
    13.3. Market Size (USD Million) Forecast for MEA 2022-2028

14. Market Share Analysis and Competitive Landscape   
    14.1. Global Landscape - Key Players, Revenue and Presence
    14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    14.3. Global Emerging Companies
    14.4. North America - Market Share Analysis and Key Regional Players
    14.5. Europe - Market Share Analysis and Key Regional Players
    14.6. Asia Pacific - Market Share Analysis and Key Regional Players
    14.7. Global Key Player - Growth Matrix

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    15.1. Pfizer Inc.
          15.1.1. Company Overview
          15.1.2. Product Portfolio
          15.1.3. SWOT Analysis
          15.1.4. Financial Overview
          15.1.5. Strategic Overview
    15.2. Johnson & Johnson
          15.2.1. Company Overview
          15.2.2. Product Portfolio
          15.2.3. SWOT Analysis
          15.2.4. Financial Overview
          15.2.5. Strategic Overview                         
    15.3. Novartis AG
          15.3.1. Company Overview
          15.3.2. Product Portfolio
          15.3.3. SWOT Analysis
          15.3.4. Financial Overview
          15.3.5. Strategic Overview
    15.4. Teva Pharmaceuticals
          15.4.1. Company Overview
          15.4.2. Product Portfolio
          15.4.3. SWOT Analysis
          15.4.4. Financial Overview
          15.4.5. Strategic Overview
    15.5. Sanofi S.A.
          15.5.1. Company Overview
          15.5.2. Product Portfolio
          15.5.3. SWOT Analysis
          15.5.4. Financial Overview
          15.5.5. Strategic Overview 

16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations

17. FutureWise SME Key Takeaway Points for Client

Tables

Figures